FX.co ★ Impact BioMedical Prices 1.5 Mln IPO At $3 Per Share

Impact BioMedical Inc. (IBO) announced on Monday that it has priced its initial public offering (IPO) at $3.00 per share for 1.5 million shares. The IPO is anticipated to close on September 17, 2024, with trading set to commence on the NYSE American Market under the ticker symbol 'IBO' starting September 16, 2024. Additionally, Impact BioMedical has provided the underwriters with a 45-day option to buy an extra 225,000 shares of its common stock.